DMED Intrinsic Valuation and Fundamental Analysis - DiagnaMed Holdings Corp

Watchlist Manager

Watchlist

Price: 0.03 CAD -14.29% Market Closed

Market Cap: CA$3.6m

D	DiagnaMed Holdings Corp CNSX:DMED	CA
S	Shimizu Corp DUS:XSZ	JP
	Diebold Nixdorf Inc F:DBDB	US
R	Ramkhamhaeng Hospital PCL SET:RAM	TH
	Ley Choon Group Holdings Ltd SGX:Q0X	SG
B	Bechtle AG DUS:BC8	DE
E	Edison International DUS:EIX	US
S	SEB SA XMUN:GRB	FR
	Bon Natural Life Ltd NASDAQ:BON	CN
C	CNB Corp OTC:CNBW	US
	Extendicare Inc TSX:EXE	CA

Intrinsic Value

Is DMED undervalued or overvalued?

See the intrinsic value estimate for DiagnaMed Holdings Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

DMED Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with DMED’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Margin of Safety 20% Locked

Current Price CA$0.03

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What DiagnaMed Does

DiagnaMed Holdings Corp. is a biotechnology company, which engages in the development and commercialization of digital therapeutics for mental health and neurological disorders. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-11-08. The firm is developing a platform of software-based prescription digital therapeutic products (PDT Products) for detecting brain age and tremors for neurological disorders.

Headquarters: Canada CA
IPO date: Nov 8, 2022